Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection
- 1 May 2008
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 118 (5) , 1776-1784
- https://doi.org/10.1172/jci33940
Abstract
Poxviruses such as the causative agent of smallpox have developed multiple strategies to suppress immune responses, including the suppression of DC activation. Since poxviruses are large DNA viruses, we hypothesized that their detection by DCs may involve the endosomal DNA recognition receptor TLR9. Indeed, we have shown here that DC recognition of ectromelia virus (ECTV), the causative agent of mousepox, completely depended on TLR9. The importance of TLR9 was highlighted by the fact that mice lacking TLR9 showed drastically increased susceptibility to infection with ECTV. In contrast, we found that the strongly attenuated poxvirus modified vaccinia virus Ankara (MVA) activated DCs by both TLR9-dependent and -independent pathways. We therefore tested whether we could use the broader induction of immune responses by MVA to protect mice from a lethal infection with ECTV. Indeed, MVA given at the same time as a lethal dose of ECTV protected mice from death. Importantly, MVA also rescued TLR9-deficient mice if administered 2 full days after an otherwise lethal infection with ECTV. Therefore, these data suggest an essential role for TLR9 in the defense against poxviruses. In addition, postexposure application of MVA may protect against lethal poxvirus infection.Keywords
This publication has 31 references indexed in Scilit:
- Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon ResponsesJournal of Virology, 2007
- Induction of Natural Killer Cell Responses by Ectromelia Virus Controls InfectionJournal of Virology, 2007
- Innate immune recognition of, and regulation by, DNATrends in Immunology, 2006
- Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus AnkaraJournal of General Virology, 2006
- Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-βBlood, 2006
- Ectromelia virus: the causative agent of mousepoxJournal of General Virology, 2005
- Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic CellsThe Journal of Experimental Medicine, 2003
- Can Postexposure Vaccination against Smallpox Succeed?Clinical Infectious Diseases, 2003
- The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host DefenseThe Journal of Experimental Medicine, 2003
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994